[Next-Generation Sequencing Book]
  • [Photo] J.W. Bizzaro • April 12, 2002
    ``Taking a position that seems to question biotech's financial underpinnings, Affymetrix Corp. last week told a government panel that gene patents are hindering medical progress and that the United States should quit handing them out.

    ```There should be no patenting of gene sequences, period. They were invented by nature,' said Barbara Caulfield, general counsel for the Santa Clara company. `This a position Affymetrix feels strongly about.'

    ``Caulfield, a noted trial attorney and former federal judge, made her declaration before the Federal Trade Commission and Department of Justice. The two agencies are studying whether patents may be stifling competition, rather than encouraging innovation, in knowledge-based industries such as biotech.''

    Full story:
    http://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2002/03/25/BU97425.DTL

Discussion forums: SF Gate: Do Gene Patents Wrap Research in Red Tape?

Expanded view | Monitor forum | Save place

Start a new thread:

You have to be logged in to post a reply.

© 1998-2025 Scilico, LLC. All rights reserved.